BMJ Best Practice

参考文献

关键文献

American Lung Association. Asthma and children fact sheet. February 2017. http://www.lungusa.org/ (last accessed 21 July 2017).

British Thoracic Society/Scottish Intercollegiate Guidelines Network. SIGN 153: British guideline on the management of asthma. A national clinical guideline. September 2016 [internet publication].

National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. August 2007. http://www.nhlbi.nih.gov/ (last accessed 21 July 2017).

Global Initiative for Asthma. 2018 GINA report: global strategy for asthma management and prevention. March 2018 [internet publication].

Global Initiative for Asthma. 2018 pocket guide for asthma management and prevention. 2018 [internet publication].

Knightly R, Milan SJ, Hughes R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017 Nov 28;11:CD003898.

Watts K, Chavasse RJ. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database Syst Rev. 2012;(5):CD006100.

Adachi M, Taniguchi H, Tohda Y, et al. The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients. J Asthma. 2012;49:649-656.

Edmonds ML, Milan SJ, Brenner BE, et al. Inhaled steroids for acute asthma following emergency department discharge. Cochrane Database Syst Rev. 2012;(12):CD002316.

参考文章

1.  Mallol J, Crane J, von Mutius E, et al; ISAAC Phase Three Study Group. The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: a global synthesis. Allergol Immunopathol (Madr). 2013;41:73-85.

2.  Centers for Disease Control and Prevention. Most recent asthma data. June 2017. https://www.cdc.gov/ (last accessed 21 July 2017).

3.  Downs SH, Marks GB, Sporik R, et al. Continued increase in the prevalence of asthma and atopy. Arch Dis Child. 2001;84:20-23.

4.  Anderson HR, Gupta R, Strachan DP, et al. 50 years of asthma: UK trends from 1955 to 2004. Thorax. 2007;62:85-90.

5.  Moorman JE, Rudd RA, Johnson CA, et al. National surveillance for asthma - United States, 1980-2004. MMWR Surveill Summ. 2007;56:1-54.

6.  Moorman JE, Akinbami LJ, Bailey CM, et al; CDC National Center for Health Statistics. National surveillance of asthma: United States, 2001-2010. Vital Health Stat. 2012;3:1-58.

7.  American Lung Association. Asthma and children fact sheet. February 2017. http://www.lungusa.org/ (last accessed 21 July 2017).

8.  Global Asthma Network. The global asthma report 2014. 2014. http://www.globalasthmareport.org/ (last accessed 21 July 2017).

9.  Toelle BG, Xuan W, Peat JK, et al. Childhood factors that predict asthma in young adulthood. Eur Respir J. 2004;23:66-70.

10.  Aberg N, Engstrom I. Natural history of allergic diseases in children. Acta Paediatr Scand. 1990;79:206-211.

11.  Almqvist C, Worm M, Leynaert B; working group of GA2LEN WP 2.5 Gender. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy. 2008;63:47-57.

12.  Johnston NW, Sears MR. Asthma exacerbations. 1: epidemiology. Thorax. 2006;61:722-728.

13.  Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. 1996;154:654-660.

14.  Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol. 2007;120:863-869.

15.  Burgess JA, Dharmage SC, Byrnes GB, et al. Childhood eczema and asthma incidence and persistence: a cohort study from childhood to middle age. J Allergy Clin Immunol. 2008;122:280-285.

16.  Greenberg SB. Respiratory consequences of rhinovirus infection. Arch Intern Med. 2003;163:278-284.

17.  Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995;310:1225-1229.

18.  Singh AM, Busse WW. Asthma exacerbations. 2: Aetiology. Thorax. 2006;61:809-816.

19.  Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis. 2004;38:1341-1346.

20.  Busse WW, O'Byrne PM, Holgate ST. Asthma pathogenesis. In: Adkinson NF Jr, Middleton E, Yunginger JW, et al, eds. Middleton's allergy: principles & practice, 6th ed. St Louis, MO: Mosby; 2003:1175-1207.

21.  O'Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med. 1991;324:359-363.

22.  Magas OK, Gunter JT, Regens JL. Ambient air pollution and daily pediatric hospitalizations for asthma. Environ Sci Pollut Res Int. 2007;14:19-23.

23.  Rossi OV, Kinnula VL, Tienari J, et al. Association of severe asthma attacks with weather, pollen, and air pollutants. Thorax. 1993;48:244-248.

24.  Leikauf GD. Hazardous air pollutants and asthma. Environ Health Perspect. 2002;110(suppl 4):505-526.

25.  Chauhan AJ, Inskip HM, Linaker CH, et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet. 2003;361:1939-1944.

26.  Anderson SD. How does exercise cause asthma attacks? Curr Opin Allergy Clin Immunol. 2006;6:37-42.

27.  Rank MA, Hagan JB, Park MA, et al. The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2013;131:724-729.

28.  Sin DD, Sutherland ER. Obesity and the lung: 4. Obesity and asthma. Thorax. 2008;63;1018-1023.

29.  British Thoracic Society/Scottish Intercollegiate Guidelines Network. SIGN 153: British guideline on the management of asthma. A national clinical guideline. September 2016 [internet publication].

30.  Altamimi S, Robertson G, Jastaniah W, et al. Single-dose oral dexamethasone in the emergency management of children with exacerbations of mild to moderate asthma. Pediatr Emerg Care. 2006;22:786-793.

31.  Thien F. Asthma: its phenotypes and the influences of analgesics. Aust J Pharmacy. 2007;88:76-80.

32.  Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;(1):CD002178.

33.  National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. August 2007. http://www.nhlbi.nih.gov/ (last accessed 21 July 2017).

34.  Yoos HL, Kitzman H, McMullen A, et al. Symptom perception in childhood asthma: how accurate are children and their parents? J Asthma. 2003;40:27-39.

35.  Global Initiative for Asthma. 2018 GINA report: global strategy for asthma management and prevention. March 2018 [internet publication].

36.  Kelly AM, Kyle E, McAlpine R. Venous pCO(2) and pH can be used to screen for significant hypercarbia in emergency patients with acute respiratory disease. J Emerg Med. 2002;22:15-19.

37.  Gorelick MH, Stevens MW, Schultz T, et al. Difficulty in obtaining peak expiratory flow measurements in children with acute asthma. Pediatr Emerg Care. 2004;20:22-26.

38.  Pellizzaro AM, Heuertz RM. C-reactive protein levels are elevated in asthma and asthma-like conditions. Clin Lab Sci. 2010;23:223-227.

39.  Saito J, Harris WT, Gelfond J, et al. Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough. Pediatr Pulmonol. 2006;41:709-719.

40.  Global Initiative for Asthma. 2018 pocket guide for asthma management and prevention. 2018 [internet publication].

41.  Garrett J, Williams S, Wong C, et al. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch Dis Child. 1998;79:12-17.

42.  Hendeles L, Sherman J. Are inhaled corticosteroids effective for acute exacerbations of asthma in children? J Pediatr. 2003;142(2 suppl):S26-S32.

43.  Kew KM, Quinn M, Quon BS, et al. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev. 2016;(6):CD007524.

44.  Martinez FD, Chinchilli VM, Morgan WJ, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:650-657.

45.  Ducharme FM. Continuous versus intermittent inhaled corticosteroids for mild persistent asthma in children: not too much, not too little. Thorax. 2012;67:102-105.

46.  Normansell R, Kew KM, Mansour G. Different oral corticosteroid regimens for acute asthma. Cochrane Database Syst Rev. 2016;(5):CD011801.

47.  Chang AB, Clark R, Sloots TP, et al. A 5- versus 3-day course of oral corticosteroids for children with asthma exacerbations who are not hospitalised: a randomised controlled trial. Med J Aust. 2008;189:306-310.

48.  Echeverria Zudaire L, Tomico Del Rio M, Bracamonte Bermejo T, et al. Status asthmaticus: is respiratory physiotherapy necessary? Allergol Immunopathol (Madr). 2000;28:290-291.

49.  Asher MI, Douglas C, Airy M, et al. Effects of chest physical therapy on lung function in children recovering from acute severe asthma. Pediatr Pulmonol. 1990;9:146-151.

50.  Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360:339-353.

51.  Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2013;(9):CD000052.

52.  Vuillermin P, South M, Robertson C. Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children. Cochrane Database Syst Rev. 2006;(3):CD005311.

53.  Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database Syst Rev. 2003;(4):CD001115.

54.  Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993;21:1479-1486.

55.  Roberts G, Newsom D, Gomez K, et al. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax. 2003;58:306-310.

56.  Mitra AA, Bassler D, Watts K, et al. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev. 2005;(2):CD001276.

57.  Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child. 1998;79:405-410.

58.  Silveira D'Avila R, Piva J, Cauduro Marostica PJ, et al. Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma. Respir Med. 2008;102:156-161.

59.  Travers AH, Jones AP, Camargo CA Jr, et al. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane Database Syst Rev. 2012;(12):CD010256.

60.  Powell C, Kolamunnage-Dona R, Lowe J, et al. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial. Lancet Respir Med. 2013;1:301-308.

61.  Knightly R, Milan SJ, Hughes R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017 Nov 28;11:CD003898.

62.  Alansari K, Ahmed W, Davidson BL, et al. Nebulized magnesium for moderate and severe pediatric asthma: a randomized trial. Pediatr Pulmonol. 2015;50:1191-1199.

63.  Schramm CM, Carroll CL. Advances in treating acute asthma exacerbations in children. Curr Opin Pediatr. 2009;21:326-332.

64.  Meduri GU, Cook TR, Turner RE, et al. Noninvasive positive pressure ventilation in status asthmaticus. Chest. 1996;110:767-774.

65.  Langton Hewer S, Hobbs J, Reid F, et al. Prednisolone in acute childhood asthma: clinical responses to three dosages. Respir Med. 1998;92:541-546.

66.  Storr J, Barrell E, Barry W, et al. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1987;1:879-882.

67.  Ho L, Landau LI, Le Souef PN. Lack of efficacy of single-dose prednisolone in moderately severe asthma. Med J Aust. 1994;160:701-704.

68.  Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2013;(8):CD000060.

69.  Sears MR. Inhaled beta agonists. Ann Allergy. 1992;68:446.

70.  Everard ML, Bara A, Kurian M, et al. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev. 2005;(3):CD001279.

71.  Hendeles L. Selecting a systemic corticosteroid for acute asthma in young children. J Pediatr. 2003;142(2 suppl):S40-S44.

72.  Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child. 2005;90:74-77.

73.  Rowe BH, Bretzlaff JA, Bourdon C, et al. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med. 2000;36:181-190.

74.  Johnston JJE. Is there a role for nebulised magnesium in the emergency department? A systematic review of the literature. J Emerg Med Trauma Acute Care. 2008;8:13-23.

75.  Kirby C. Comparison of intravenous and inhaled salbutamol in severe acute asthma. Pediatr Rev Commun. 1988;3:67-77.

76.  Browne GJ, Penna AS, Phung X, et al. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet. 1997;349:301-305.

77.  Browne GJ, Lam LT. Single-dose intravenous salbutamol bolus for managing children with acute severe asthma in the emergency department: reanalysis of data. Pediatr Crit Care Med. 2002;3:117-123.

78.  Travers A, Jones AP, Kelly K, et al. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev. 2001:(1):CD002988.

79.  Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev. 2006;(4):CD002884.

80.  Kim IK, Phrampus E, Venkataraman S, et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics. 2005;116:1127-1133.

81.  Dworski R, Fitzgerald GA, Oates JA, et al. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med. 1994;149:953-959.

82.  Camargo CA Jr, Smithline HA, Malice MP, et al. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med. 2003;167:528-533.

83.  Watts K, Chavasse RJ. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database Syst Rev. 2012;(5):CD006100.

84.  Adachi M, Taniguchi H, Tohda Y, et al. The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients. J Asthma. 2012;49:649-656.

85.  Morris CR, Becker AB, Piñieiro A, et al. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma. Ann Allergy Asthma Immunol. 2010;104:161-171.

86.  Todi VK, Lodha R, Kabra SK. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial. Arch Dis Child. 2010;95:540-543.

87.  Harmanci K, Bakirtas A, Turktas I, et al. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol. 2006;96:731-735.

88.  Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med. 2007;175:323-329.

89.  Bacharier LB, Phillips BR, Zeiger RS, et al; CARE Network. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol. 2008;122:1127-1135.e8.

90.  Schumock GT, Lee TA, Joo MJ, et al. Association between leukotriene-modifying agents and suicide: what is the evidence? Drug Saf. 2011;34:533-544.

91.  O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171:129-136.

92.  Bisgaard H, Le Roux P, Bjamer D, et al. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest. 2006;130:1733-1743.

93.  Cates CJ, Lasserson TJ. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. Cochrane Database Syst Rev. 2009;(1):CD007085.

94.  Cates CJ, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;(4):CD007313.

95.  Chapman KR, Barnes NC, Greening AP, et al. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. Thorax. 2010;65:747-752.

96.  Pavord ID, Jeffery PK, Qiu Y, et al. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. J Allergy Clin Immunol. 2009;123:1083-1089,1089.e1-1089.e7.

97.  Rodrigo GJ, Moral VP, Marcos LG, et al. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review. Pulm Pharmacol Ther. 2009;22:9-19.

98.  Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev. 2008;(3):CD006363.

99.  Price JF, Radner F, Lenney W, et al. Safety of formoterol in children and adolescents: experience from asthma clinical trials. Arch Dis Child. 2010;95:1047-1053.

100.  Rodrigo GJ, Neffen H, Colodenco FD, et al. Formoterol for acute asthma in the emergency department: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2010;104:247-252.

101.  Bussamra MH, Stelmach R, Rodrigues JC, et al. A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting. Ann Allergy Asthma Immunol. 2009;103:248-253.

102.  Arun JJ, Lodha R, Kabra SK. Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial. BMC Pediatr. 2012;12:21.

103.  Gupta R, Strachan D. The health of children and young people. Asthma and allergic diseases. London, UK: Office for National Statistics. 2004.

104.  Bergstrom SE, Boman G, Eriksson L, et al. Asthma mortality among Swedish children and young adults, a 10-year study. Respir Med. 2008;102:1335-1341.

105.  Malmstrom K, Kaila M, Kajosaari M, et al. Fatal asthma in Finnish children and adolescents 1976-1998: validity of death certificates and a clinical description. Pediatr Pulmonol. 2007;42:210-215.

106.  Roberts G, Patel N, Levi-Schaffer F, et al. Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol. 2003;112:168-174.

107.  O'Byrne PM, Pedersen S, Lamm CJ, et al. START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009;179:19-24.

108.  Stack AM, Caputo GL. Pneumomediastinum in childhood asthma. Pediatr Emerg Care. 1996;12:98-101.

109.  Kravis LP. An analysis of fifteen childhood asthma fatalities. J Allergy Clin Immunol. 1987;80:467-472.

110.  Mannix R, Bachur R. Status asthmaticus in children. Curr Opin Pediatr. 2007;19:281-287.

111.  Edmonds ML, Milan SJ, Brenner BE, et al. Inhaled steroids for acute asthma following emergency department discharge. Cochrane Database Syst Rev. 2012;(12):CD002316.

112.  Edmonds ML, Milan SJ, Camargo-Jr CA, et al. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev. 2012;(12):CD002308.

113.  Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA): 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63:8-160.

114.  Wolf FM, Guevara JP, Grum CM, et al. Educational interventions for asthma in children. Cochrane Database Syst Rev. 2002;(4):CD000326.

115.  Ducharme FM, Zemek RL, Chalut D, et al. Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control. Am J Respir Crit Care Med. 2011;183:195-203.

116.  Cano-Garcinuno A, Diaz-Vazquez C, Carvajal-Uruena I, et al. Group education on asthma for children and caregivers: a randomized, controlled trial addressing effects on morbidity and quality of life. J Investig Allergol Clin Immunol. 2007;17:216-226.

117.  Zemek RL, Bhogal SK, Ducharme FM. Systematic review of randomized controlled trials examining written action plans in children: what is the plan? Arch Pediatr Adolesc Med. 2008;162:157-163.

118.  Chang AB, Taylor B, Masters IB, et al. Indigenous healthcare worker involvement for indigenous adults and children with asthma. Cochrane Database Syst Rev. 2010;(5):CD006344.

119.  Flores G, Bridon C, Torres S, et al. Improving asthma outcomes in minority children: a randomized, controlled trial of parent mentors. Pediatrics. 2009;124:1522-1532.

120.  Boyd M, Lasserson TJ, McKean MC, et al. Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev. 2009;(2):CD001290.

121.  Bravata DM, Gienger AL, Holty JE, et al. Quality improvement strategies for children with asthma: a systematic review. Arch Pediatr Adolesc Med. 2009;163:572-581.

122.  Coffman JM, Cabana MD, Halpin HA, et al. Effects of asthma education on children's use of acute care services: a meta-analysis. Pediatrics. 2008;121:575-586.

123.  Lavorini F, Magnan A, Dubus JC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593-604.

124.  Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother. 2009;43:85-97.

125.  Vuillermin PJ, Robertson CF, Carlin JB, et al. Parent initiated prednisolone for acute asthma in children of school age: randomised controlled crossover trial. BMJ. 2010;340:c843.

126.  Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet. 2003;362:1433-1438.

127.  Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2013;(2):CD000364.

128.  Pedroza A, Huerta JG, Garcia Mde L, et al. The safety and immunogenicity of influenza vaccine in children with asthma in Mexico. Int J Infect Dis. 2009;13:469-475.

129.  Sheikh A, Alves B, Dhami S. Pneumococcal vaccine for asthma. Cochrane Database Syst Rev. 2002;(1):CD002165.

130.  Wilson SR, Farber HJ, Knowles SB, et al. A randomized trial of parental behavioral counseling and cotinine feedback for lowering environmental tobacco smoke exposure in children with asthma: results of the LET'S Manage Asthma trial. Chest. 2011;139:581-590.

使用此内容应接受我们的免责声明。